참고문헌
- Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood 2005. 106: 3343-3347. 椄 돀'⨀ 塨?⨀ 育⨀ 䄄 돐 쁖잖⨀ 쁖잖⨀ ꢲ⨀ ᤄ 덐 뢲⨀ ᠄ 紀 コ⨀
- Boven K, Knight J, Bader F, Rossert J, Eckardt KU, Casadevall N. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery. Nephrol Dial Transplant 2005. 20 Suppl 3: iii33-40. https://doi.org/10.1093/ndt/gfh1072
- Boven K, Stryker S, Knight J, Thomas A, van Regenmortel M, Kemeny DM, Power D, Rossert J, Casadevall N. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int. 2005. 67: 2346-2353. https://doi.org/10.1111/j.1523-1755.2005.00340.x
- Casadevall N, Cournoyer D, Marsh J, Messner H, Pallister C, Parker-Williams J, Rossert J. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia. Eur J Haematol. 2004. 73: 389-396. https://doi.org/10.1111/j.1600-0609.2004.00348.x
- Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med. 1996. 334: 630-633. https://doi.org/10.1056/NEJM199603073341004
- Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin- Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002. 346: 469-475. https://doi.org/10.1056/NEJMoa011931
- Datamonitor. Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010: Market Research.com 2002. p. 252.
- Eckardt KU, Casadevall N. Pure red-cell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 2003. 18: 865-869. https://doi.org/10.1093/ndt/gfg182
- Gribben JG, Devereux S, Thomas NS, Keim M, Jones HM, Goldstone AH, Linch DC. Development of antibodies to unprotected glycosylation sites on recombinant human GMCSF. Lancet 1990. 335: 434-437. https://doi.org/10.1016/0140-6736(90)90665-R
- Johnson & Johnson Pharmaceutical Research & Development LLC. Summary of PRCA Case Reports. Available at: http:// www.jnjpharmarnd.com/company/news.html, 2008.
- Krantz SB. Pure red-cell aplasia. N Engl J Med. 1974. 291: 345 -350. https://doi.org/10.1056/NEJM197408152910707
- Ottesen JL, Nilsson P, Jami J, Weilguny D, Duhrkop M, Bucchini D, Havelund S, Fogh JM. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia 1994. 37: 1178-1185. https://doi.org/10.1007/BF00399790
- Palleroni AV, Aglione A, Labow M, Brunda MJ, Pestka S, Sinigaglia F, Garotta G, Alsenz J, Braun A. Interferon immunogenicity: preclinical evaluation of interferon-alpha 2a. J Interferon Cytokine Res. 1997. 17 Suppl 1: S23-27.
- Schellekens H. Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin Ther. 2002. 24: 1720 -1740; discussion 1719. https://doi.org/10.1016/S0149-2918(02)80075-3
- Schellekens H. Immunogenicity of therapeutic proteins. Nephrol Dial Transplant 2003. 18: 1257-1259. https://doi.org/10.1093/ndt/gfg164
- Schellekens H, Jiskoot W. Eprex-associated pure red cell aplasia and leachates. Nat Biotechnol. 2006. 24: 613-614. https://doi.org/10.1038/nbt0606-613
- Stewart TA, Hollingshead PG, Pitts SL, Chang R, Martin LE, Oakley H. Transgenic mice as a model to test the immunogenicity of proteins altered by site-specific mutagenesis. Mol Biol Med. 1989. 6: 275-281.
- Swanson SJ, Ferbas J, Mayeux P, Casadevall N. Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin. Nephron Clin Pract. 2004. 96: c88-95. https://doi.org/10.1159/000076746
- Thorpe R, Swanson SJ. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures. Nephrol Dial Transplant 2005. 20 Suppl 4: iv16-22. https://doi.org/10.1093/ndt/gfh1086
- Thorpe R, Swanson SJ. Current methods for detecting antibodies against erythropoietin and other recombinant proteins. Clin Diagn Lab Immunol. 2005. 12: 28-39
- Verhelst D, Rossert J, Casadevall N, Kruger A, Eckardt KU, Macdougall IC. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study. Lancet 2004. 363: 1768 -1771. https://doi.org/10.1016/S0140-6736(04)16302-2
- Yang J, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Lee JS. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies. J Nephrol. 2005. 18: 102-105.